Home Weight loss (GLP-1) By state West Virginia
PEIA's Paused GLP-1 Pilot: 8 programs ship to WV
West Virginia was early to cover GLP-1s for weight loss and early to pull back. PEIA ran a pilot for state workers, then paused it on March 15, 2024. With adult obesity at 37.4%, seventh highest among the states with a 2025 estimate, the demand didn't go away when the coverage did. The lowest price we found from a program that ships to West Virginia: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
West Virginia at a glance
- West Virginia Medicaid
- Does not cover for weight loss
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 37.4% (2025)
- Programs we compare that ship to WV
- 8 of 22
Online GLP-1 programs for West Virginia, cheapest first
Programs that ship to West Virginia. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in West Virginia: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in West Virginia: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Why PEIA paused, and where West Virginians turned next
PEIA's pilot covered GLP-1s for obesity for about 1,000 public employees. In March 2024 the state said it would pause the pilot indefinitely, citing a gross cost of about $1.4 million a month, according to the Associated Press. PEIA still covers GLP-1s for type 2 diabetes. Members of the pilot had to find another way to pay, and the plan has not announced a restart.
West Virginia Medicaid doesn't cover GLP-1s for obesity either, according to KFF. The AP noted that about half of West Virginians rely on Medicare or Medicaid for their insurance, which makes the Medicaid gap a big one. Medicare members may now qualify for the federal GLP-1 Bridge, which started in July 2026. It offers a $50 copay to eligible Part D enrollees through the end of 2027.
For everyone else, the answer is a cash program. In a state with long drives between towns, online care has a real advantage: the visit happens from home, and the medication is mailed to your door. Every program in our comparison says on its own site that it ships to West Virginia. Prices are the same whether you live in Charleston, Morgantown or a county with no specialist at all.
- PEIA paused coverage of weight-loss GLP-1s on March 15, 2024; GLP-1s remain covered for type 2 diabetes. (peia.wv.gov)
- The AP reported that West Virginia's PEIA pilot covered about 1,000 public employees and was paused, with the state citing a gross cost of $1.4 million a month. (ksat.com)
- KFF's January 2026 review lists West Virginia Medicaid as not covering GLP-1s for obesity. (kff.org)
- West Virginia's adult obesity rate was 37.4% in 2025, seventh highest among the states with a 2025 estimate. (cdc.gov)
- The Medicare GLP-1 Bridge began July 1, 2026 with a $50 copay for eligible Part D enrollees. (cms.gov)
- PEIA's financial statements for fiscal 2025 say GLP-1 medications represented 18.1% of overall cost in its pharmacy benefit manager's 2025 annual review, and that members with prior authorizations when coverage stopped could continue until they expired, typically after 12 months. (peia.wv.gov)
- West Virginia Medicaid's Zepbound criteria (effective July 1, 2025) consider coverage only for obstructive sleep apnea in adults with obesity, requiring a sleep study with an AHI of 15 or more in the past 12 months and a BMI of 30 or more. (bms.wv.gov)
- West Virginia House Bill 5153, introduced February 3, 2026, would require insurance coverage of GLP-1 medications for anyone with a valid prescription; it was referred to Health and Human Resources and never left that first committee. (bills.wvlegislature.gov)
- In 2025, 36.0% of West Virginia adults aged 60 and older had obesity, tied for fifth highest for that age group among the states with data. (cdc.gov)
What the pause did to PEIA's drug bill
PEIA's own financial statements explain the decision in numbers. In its pharmacy benefit manager's 2025 annual review, diabetes medicines were the plan's top drug expense at 26% of the total, and GLP-1s alone made up 18.1%. When PEIA stopped covering weight-loss medication on March 15, 2024, members who already had a prior authorization could keep filling until it expired, typically after 12 months. As those approvals ran out, PEIA's net drug claims cost for 2025 rose only 2.5%.
Lawmakers have tried to push the other way. House Bill 5153, introduced on February 3, 2026, would have required state-regulated insurance to cover GLP-1 drugs for anyone with a valid prescription. It was referred to the House Health and Human Resources Committee (then Finance) and never left the first committee. As written, it adds a section to the state insurance code rather than changing PEIA's own rules. For now PEIA covers GLP-1s only for diabetes.
West Virginia Medicaid's one GLP-1 exception: sleep apnea
West Virginia Medicaid treats weight-loss drugs as a benefit exclusion. Its prior authorization criteria for Zepbound, effective July 1, 2025, say coverage will be considered only for moderate to severe obstructive sleep apnea in adults with obesity. The request needs a sleep study from the past 12 months showing 15 or more breathing events an hour, a BMI of 30 or higher recorded in the past three months, and proof that CPAP was prescribed or discussed.
There are more conditions. The patient must get ongoing counseling on diet and activity, can't combine Zepbound with any other tirzepatide product, and, if they also have type 2 diabetes, must first have tried a preferred diabetes GLP-1 for three months without success. Renewal needs documented improvement in sleep apnea plus weight loss of more than 5%, or keeping off the first 5%. Anyone without sleep apnea is outside this path.
Older West Virginians have the most to gain from Medicare's change
West Virginia's obesity rate stays high into later life. The CDC's 2025 survey found it in 36.0% of adults 60 and older, tied for the fifth highest rate for that age group among the states with data, and in 45.3% of adults 40 to 59. CDC data pooled for 2023 to 2025 put the rate for white adults in the state at 40.5%.
That makes the Medicare GLP-1 Bridge more relevant here than in most states. Since July 1, 2026, eligible Part D enrollees can get certain GLP-1 weight-loss drugs for a $50 copay, through the end of 2027. Younger adults, and anyone who doesn't qualify, are back to cash programs, which mail medication to Wheeling, Beckley and every county in between at one statewide price.
GLP-1 in West Virginia: questions
Does PEIA cover Wegovy or Zepbound for weight loss now?
No. PEIA paused weight-loss GLP-1 coverage on March 15, 2024, and it still covers GLP-1s only for type 2 diabetes. No restart date has been announced. Public employees who want a GLP-1 for weight usually pay cash. The programs compared on this page list their own monthly prices.
What was the PEIA GLP-1 pilot?
It was a program that covered GLP-1s for obesity for about 1,000 West Virginia public employees. In March 2024 the state paused it indefinitely, citing a gross cost of about $1.4 million a month. Many people in the pilot had to find another way to pay. Online cash programs became a common choice.
Does West Virginia Medicaid cover GLP-1s for weight loss?
No. KFF's January 2026 review lists West Virginia Medicaid as not covering GLP-1s for obesity. GLP-1s for type 2 diabetes are a separate benefit with prior authorization. If you're on Medicaid and want treatment for weight alone, the programs on this page are the usual route, with prices shown up front.
Can I get a GLP-1 delivered if I live in a rural West Virginia county?
Yes. The programs in our comparison ship by mail anywhere in West Virginia, so you don't need a nearby clinic or a pharmacy that stocks GLP-1s. Shots usually ship in cold packaging. Your visit happens online, by video or a form a clinician reviews. Check each program's delivery terms in the cards above.
Is a compounded GLP-1 cheaper than a brand-name one for West Virginians?
Usually, yes. Compounded semaglutide and tirzepatide from online programs cost far less per month than brand-name list prices, and some programs keep one price at every dose. If you want a brand-name drug, programs like Maximus offer Wegovy and Zepbound too. Compare both kinds in the table above.
Does West Virginia Medicaid cover Zepbound for sleep apnea?
It can. Since July 1, 2025, West Virginia Medicaid considers Zepbound only for moderate to severe obstructive sleep apnea in adults with obesity. You need a recent sleep study showing 15 or more events an hour, a BMI of 30 or more, and a CPAP prescription or discussion. Renewal needs documented improvement in sleep apnea plus weight loss of more than 5%, or keeping off the first 5%. Weight loss alone isn't covered.
Is there a bill to make insurers cover GLP-1s in West Virginia?
One was filed. House Bill 5153, introduced February 3, 2026, would require state-regulated insurance to cover GLP-1 drugs with a valid prescription. It was referred to the Health and Human Resources Committee and got no further. As written it amends the insurance code, not PEIA's rules, and PEIA still covers GLP-1s only for diabetes. For now, cash programs are the dependable route.
See programs for West Virginia All states
Sources: kff.org · cdc.gov · peia.wv.gov